居家透析与中心血透主要不良心血管事件风险比较
芬兰2004–2017年968例透析患者队列中,居家透析与中心血透的主要不良心血管事件(MACE)风险总体相当;但腹膜透析在女性中与较低MACE风险相关,在男性中与较高风险相关,需进一步研究。
要点
- 居家透析与中心血透的MACE累积发生率及校正后风险总体无差异。
- 腹膜透析女性MACE风险低于中心血透(HR 0.37),男性则高于中心血透(HR 1.80)。
- 该性别差异属意外发现,需进一步研究验证。
核心结论
- 在该队列中,中心血透与居家透析各模式的MACE风险总体相当。
- 腹膜透析与中心血透相比,女性MACE风险较低、男性较高,需进一步研究。
研究设计与样本
- 芬兰Helsinki-Uusimaa医疗区2004–2017年进入透析的968例患者队列。
- 透析开始第90天时,162例持续不卧床腹膜透析、229例自动腹膜透析、145例居家血透、432例中心血透。
- MACE定义为急性心肌梗死、卒中或心血管病死亡,采用Cox回归校正潜在混杂因素。
主要发现
- 968例中195例(20%)随访期间发生MACE,62例(6%)在随访第一年发生。
- 中心血透与持续不卧床腹膜透析的首发MACE累积发生率相近,且高于自动腹膜透析和居家血透。
- 校正混杂后,以中心血透为参照,持续不卧床腹膜透析HR 1.22(95%CI 0.73–2.05),自动腹膜透析HR 0.86(95%CI 0.47–1.57),居家血透HR 0.67(95%CI 0.30–1.50)。
- 腹膜透析与中心血透相比,女性MACE的HR 0.37(95%CI 0.14–0.99),男性HR 1.80(95%CI 1.11–2.92)。
临床怎么用
- 选择透析模式时,总体MACE风险在中心血透与居家透析间未见差异。
- 对女性患者可关注腹膜透析的潜在心血管获益,对男性患者需警惕腹膜透析相关风险。
- 性别差异需结合其他研究验证后再用于个体化决策。
局限性
- 为观察性队列,可能存在未校正混杂。
- 性别差异为意外发现,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: We observed a comparable cumulative incidence of major adverse cardiovascular event (MACE) in in-center hemodialysis (IC-HD) and continuous ambulatory peritoneal dialysis (PD) patients, which was higher than in automated PD and home hemodialysis patients. After adjustment for confounders, there was no difference in risk of MACE between patients on home dialysis modalities and IC-HD. Compared with IC-HD, PD was associated with lower risk of MACE among female patients and higher risk among male patients. BACKGROUND: Among dialysis patients, cardiovascular events are the leading cause of death. Little is known about how the frequency and type of cardiovascular events differ between various dialysis modalities. We compared risk of major adverse cardiovascular events (MACEs) in patients who started continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD), and home hemodialysis with in-center hemodialysis (IC-HD) patients. METHODS: We included 968 patients who entered dialysis in the Helsinki-Uusimaa health care district in Finland from 2004 to 2017, of whom 162 were on CAPD, 229 on APD, 145 on home hemodialysis, and 432 on IC-HD at day 90 from the start of dialysis. MACE was defined as acute myocardial infarction, stroke, or death due to cardiovascular disease. The cumulative incidence of the first MACE was calculated. Cox regression was used to compare risk of MACE between dialysis modalities with adjustment for potential confounding factors. RESULTS: Of all 968 patients, 195 (20%) experienced a MACE during the entire follow-up and 62 (6%) during the first year of follow-up. The cumulative incidence of first MACE was similar in IC-HD and CAPD patients and higher than that in APD and home hemodialysis patients. After adjustment for possible confounders, the hazard ratio (HR) of MACE was 1.22 (95% confidence intervals [CIs], 0.73 to 2.05) for CAPD, 0.86 (95% CI, 0.47 to 1.57) for APD and 0.67 (95% CI, 0.30 to 1.50) for home hemodialysis compared with IC-HD. Unexpectedly, compared with IC-HD, peritoneal dialysis associated with lower risk of MACE among female patients (HR, 0.37; 95% CI, 0.14 to 0.99) and higher risk among male patients (HR, 1.80; 95% CI, 1.11 to 2.92). CONCLUSIONS: In this cohort, the risk of MACE was comparable across in-center and home dialysis modalities. However, the result differed between male patients and female patients, which requires further research.
引用
- Bitar W, Helve J, Haapio M, et al. Risk of Major Adverse Cardiovascular Events in Home Dialysis Compared With In-Center Hemodialysis. Clin J Am Soc Nephrol. 2024. PMID: 39792539. doi:10.2215/CJN.0000000579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。